Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Fighting against infections with beneficial bacteria

20.01.2003


By using mouse models, the EU-funded DEPROHEALTH-project has demonstrated that some lactobacilli can have a beneficial effect on intestinal inflammation and infections. The major target disease in these mouse studies has been inflammation of the bowel. For this purpose, engineered lactobacilli were constructed. The modified strains that are most promising produce fair levels of an effective compound (an interleukine) that helps preventing the inflammation caused by bacteria. Four of the most promising candidate strains have been selected for future studies. These studies will test the effect of these strains in mice, in order to prepare future studies in humans.

Finding the effective bacteria has required a lot of background work. The research started with examining a number of wild strains of lactobacilli to find out about their potential capacity to interact with the host immune system. Ideally the beneficial bacteria should be taken orally, so their ability to survive passage trough the upper part of the intestinal tract is important and was indeed investigated. The acidic conditions in the stomach or the bile salts in the intestine may destroy their potential favourable influences.

DEPROHEALTH-project aims to design specific beneficial probiotic strains to avert intestinal illnesses. The project is developing new ways to tackle these illnesses by oral treatment which is much easier to administer than injections. Diseases targeted in the project are stomach ulcers linked with Helicobacter pylori, and infant diarrhoea, which is commonly caused by rotavirus. It also seeks to develop a new treatment against life long malign intestinal inflammation, such as Crohn’s disease, which severely affect the patient’s quality of life.



Further information, please contact:

Dr, Annick Mercenier
Institut Pasteur de Lille
1, rue du Pr. Calmette
PB 245
F-59019 Lille Cedex
France

Tel. +41 21 785 84 66
Fax: +41 21 785 85 49
e-mail: annick.mercenier@rdls.nestle.com

Dr. Annick Mercenier | Institut Pasteur de Lille
Further information:
http://www.vtt.fi/virtual/proeuhealth/index.htm

More articles from Health and Medicine:

nachricht Nanoparticles as a Solution against Antibiotic Resistance?
15.12.2017 | Friedrich-Schiller-Universität Jena

nachricht Plasmonic biosensors enable development of new easy-to-use health tests
14.12.2017 | Aalto University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First-of-its-kind chemical oscillator offers new level of molecular control

DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.

Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...

Im Focus: Long-lived storage of a photonic qubit for worldwide teleportation

MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.

Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...

Im Focus: Electromagnetic water cloak eliminates drag and wake

Detailed calculations show water cloaks are feasible with today's technology

Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Engineers program tiny robots to move, think like insects

15.12.2017 | Power and Electrical Engineering

One in 5 materials chemistry papers may be wrong, study suggests

15.12.2017 | Materials Sciences

New antbird species discovered in Peru by LSU ornithologists

15.12.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>